effect of propolis in COVID-19

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2020
INTERVENTION: Intervention 1: Intervention group: The propolis supplement is taken as a 500 mg capsule twice a day for 1 month. Intervention 2: Control group: The placebo is taken as a capsule twice a day for 1 month. CONDITION: Covid‐19. ; Other coronavirus as the cause of diseases classified elsewhere U07.1 PRIMARY OUTCOME: Body temperature. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. CBC. Timepoint: First and 30 days after the intervention. Method of measurement: Cell counter. Cough. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. Crp‐hs. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA. LI‐6. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA. Oxygen saturation. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. Respiratory rate. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. TNF alpha. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA. INCLUSION CRITERIA: Patients aged 18 to 65 years Laboratory confirmation of Covid‐19 (2019‐nCoV Real‐Time RT‐PCR)
Epistemonikos ID: 142ad0b09d5d1059ad4e722ef4dd3227cdcf60d4
First added on: May 10, 2020